Sylvia Smith

Dr. Sylvia Smith


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JWJing Wang
Jing Wang
ASAlan Saul
Alan Saul
PRPenny Roon
Penny Roon
SSSylvia Smith
Sylvia Smith
Significance: The role of sigma 1 receptor (Sig1R) in rescuing cone photoreceptor function was investigated in Pde6β rd10 ( rd10 ) mice, a model of severe retinal degeneration. Sig1R, a putative molecular chaperone, is implicated in several human neurodegenerative diseases. We administered (+)-pentazocine, a high-affinity Sig1R ligand, to rd10 mice, which lose rod and subsequently cone photoreceptor cells (PRC) within the first few weeks of life, rendering them completely blind. Regular administration of (+)-pentazocine rescued cone PRC responses, which were markedly preserved and were similar to those in wild-type mice. To our knowledge, this is the first demonstration of significant preservation of retinal function as a consequence of Sig1R activation. The data are highly relevant to potential therapeutic interventions in human retinal disease.

1 November 2018 in Progress in Retinal and Eye Research
Verified
Journal Article
Closed access
SSSylvia Smith
Sylvia Smith
JWJing Wang
Jing Wang
XCXuezhi Cui
Xuezhi Cui
BMBarbara A. Mysona
Barbara A. Mysona
JZJing Zhao
Jing Zhao
KBKathryn E. Bollinger
Kathryn E. Bollinger

1 June 2019 in Redox Biology
Verified
Journal Article
Open access
SNSoumya Navneet
Soumya Navneet
JZJing Zhao
Jing Zhao
JWJing Wang
Jing Wang
BMBarbara Mysona
Barbara Mysona
SBShannon Barwick
Shannon Barwick
SSSylvia Smith
Sylvia Smith
Hyperhomocysteinemia (Hhcy), or increased levels of the excitatory amino acid homocysteine (Hcy), is implicated in glaucoma, a disease characterized by increased oxidative stress and loss of retinal ganglion cells (RGCs). Whether Hhcy is causative or merely a biomarker for RGC loss in glaucoma is unknown. Here we analyzed the role of NRF2, a master regulator of the antioxidant response, in Hhcy-induced RGC death in vivo and in vitro. By crossing Nrf2-/- mice and two mouse models of chronic Hhcy (Cbs+/- and Mthfr+/- mice), we generated Cbs+/-Nrf2-/- and Mthfr+/-Nrf2-/- mice and performed systematic analysis of retinal architecture and visual acuity followed by assessment of retinal morphometry and gliosis. We observed significant reduction of inner retinal layer thickness and reduced visual acuity in Hhcy mice lacking NRF2. These functional deficits were accompanied by fewer RGCs and increased gliosis. Given the key role of Müller glial cells in maintaining RGCs, we established an ex-vivo indirect co-culture system using primary RGCs and Müller cells. Hhcy-exposure decreased RGC viability, which was abrogated when cells were indirectly cultured with wildtype (WT) Müller cells, but not with Nrf2-/- Müller cells. Exposure of WT Müller cells to Hhcy yielded a robust mitochondrial and glycolytic response, which was not observed in Nrf2-/- Müller cells. Taken together, the in vivo and in vitro data suggest that deleterious effects of Hhcy on RGCs are likely dependent upon the health of retinal glial cells and the availability of an intact retinal antioxidant response mechanism.

1 April 2019 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JWJing Wang
Jing Wang
JZJ. Zhao
J. Zhao
XCX. Cui
X. Cui
BMB.A. Mysona
B.A. Mysona
SNS. Navneet
S. Navneet
SSSylvia Smith
Sylvia Smith

1 January 2019 in Experimental Eye Research
Verified
Journal Article
Closed access
SNSoumya Navneet
Soumya Navneet
XCXuezhi Cui
Xuezhi Cui
JZJing Zhao
Jing Zhao
JWJing Wang
Jing Wang
NKNavneet Ammal Kaidery
Navneet Ammal Kaidery
SSSylvia Smith
Sylvia Smith

25 January 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FLFang Liu
Fang Liu
ASAlan Saul
Alan Saul
PPPrahalathan Pichavaram
Prahalathan Pichavaram
ZXZhimin Xu
Zhimin Xu
Madhuri RudrarajuMadhuri Rudraraju
Madhuri Rudraraju
SNS. Priya Narayanan
S. Priya Narayanan
Diabetic retinopathy (DR) is a significant cause of blindness in working-age adults worldwide. Lack of effective strategies to prevent or reduce vision loss is a major problem. Since the degeneration of retinal neurons is an early event in the diabetic retina, studies to characterize the molecular mechanisms of diabetes-induced retinal neuronal damage and dysfunction are of high significance. We have demonstrated that spermine oxidase (SMOX), a mediator of polyamine oxidation is critically involved in causing neurovascular damage in the retina. The involvement of SMOX in diabetes-induced retinal neuronal damage is completely unknown. Utilizing the streptozotocin-induced mouse model of diabetes, the impact of the SMOX inhibitor, MDL 72527, on neuronal damage and dysfunction in the diabetic retina was investigated. Retinal function was assessed by electroretinography (ERG) and retinal architecture was evaluated using spectral domain-optical coherence tomography. Retinal cryosections were prepared for immunolabeling of inner retinal neurons and retinal lysates were used for Western blotting. We observed a marked decrease in retinal function in diabetic mice compared to the non-diabetic controls. Treatment with MDL 72527 significantly improved the ERG responses in diabetic retinas. Diabetes-induced retinal thinning was also inhibited by the MDL 72527 treatment. Our analysis further showed that diabetes-induced retinal ganglion cell damage and neurodegeneration were markedly attenuated by MDL 72527 treatment. These results strongly implicate SMOX in diabetes-induced retinal neurodegeneration and visual dysfunction.